Lubiprostone Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 8 mcg, 24 mcg
Reference Brands: Amitiza (USA/EU)
Category:
Gastrointestinal Drugs
Lubiprostone is used to treat chronic idiopathic constipation (CIC), constipation in patients using opioids (opioid‑induced constipation, OIC), and irritable bowel syndrome with constipation (IBS‑C) in adult women. It works by activating chloride (ClC‑2) channels in the intestinal lining, which increases fluid secretion into the intestines, softens stools, improves motility, and promotes spontaneous bowel movements.
Lubiprostone is available in Capsules
and strengths such as 8 mcg, 24 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lubiprostone is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lubiprostone can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing